Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The drugmaker, which has been dealing with talc-related